Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
40.69
+0.79 (1.98%)
At close: May 3, 2024, 4:00 PM
40.67
-0.02 (-0.05%)
After-hours: May 3, 2024, 7:21 PM EDT
BHVN Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
239
Market Cap
3.32B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 0 | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBHVN News
- 11 days ago - Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 15 days ago - Biohaven Announces Pricing of $230 Million Public Offering of Common Shares - PRNewsWire
- 16 days ago - Biohaven Announces Proposed Public Offering of Common Shares - PRNewsWire
- 20 days ago - Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates - PRNewsWire
- 2 months ago - Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments - PRNewsWire
- 4 months ago - Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncology - PRNewsWire
- 4 months ago - Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 5 months ago - Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting - PRNewsWire